| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Versant Venture Capital VII, L.P. | 10%+ Owner | $113,694,209 | 04 Apr 2022 | ||
| Ross Haghighat | Director | $4,860,906 | 26 May 2023 | ||
| Alan Glicklich | Chief Medical Officer | $307,978 | 10 Feb 2022 | ||
| Srinivas Akkaraju | Director | 11 Aug 2023 | |||
| William Mariner Greenman | Director | 11 Aug 2023 | |||
| Jerel Davis | Director | 11 Aug 2023 | |||
| Tom Frohlich | Chief Operating Officer | 11 Aug 2023 | |||
| ERIC DOBMEIER | President, CEO, Director | 11 Aug 2023 | |||
| Dolca Thomas | Director | 11 Aug 2023 | |||
| Andrew James King | Chief Scientific Officer | 11 Aug 2023 | |||
| Mahesh Krishnan | Director | 11 Aug 2023 | |||
| Andrew Oxtoby | Chief Commercial Officer | 11 Aug 2023 | |||
| Robert Azelby | Director | 11 Aug 2023 | |||
| MICHELLE RENEE GRIFFIN | Director | 11 Aug 2023 | |||
| ERIC BJERKHOLT | Chief Financial Officer | 11 Aug 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|